Literature DB >> 21441137

Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model--brief report.

Susan T Laing1, Melanie Moody, Beverly Smulevitz, Hyunggun Kim, Patrick Kee, Shaoling Huang, Christy K Holland, David D McPherson.   

Abstract

OBJECTIVE: Ultrasound enhances thrombolysis when combined with a thrombolytic and a contrast agent. This study aimed to evaluate the thrombolytic effect of our tissue plasminogen activator (tPA)-loaded echogenic liposomes (ELIP) in an in vivo clot model, with and without ultrasound treatment. METHODS AND
RESULTS: The femoral arteries of New Zealand White rabbits (n=4 per group) were cannulated. The abdominal aortas were denuded, and thrombi were created using a solution of sodium ricinoleate plus thrombin. Rabbits were then randomly selected to receive tPA-loaded ELIP (200 μg of tPA/5 mg of lipid) or empty ELIP with or without pulsed (color) Doppler ultrasound (5.7 MHz) for 2 minutes. Thrombus was imaged and echogenicity analyzed before and after ELIP injection. Blood flow velocities were measured at baseline, after clot formation, and serially after treatment up to 15 minutes. tPA-loaded ELIP highlighted thrombus in the abdominal aorta more effectively than empty ELIP (P<0.05). Ultrasound enhanced the thrombolytic effect of tPA-loaded ELIP, resulting in earlier and more complete recanalization rates (P<0.001).
CONCLUSION: This study demonstrates effective highlighting of clots and thrombolytic effect of tPA-loaded ELIP in an in vivo rabbit aorta clot model. Doppler ultrasound treatment enhances this thrombolytic effect, resulting in earlier and more complete recanalization rates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441137      PMCID: PMC3287366          DOI: 10.1161/ATVBAHA.111.225938

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound.

Authors:  Denise A B Smith; Tyrone M Porter; Janet Martinez; Shaoling Huang; Robert C MacDonald; David D McPherson; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2007-04-06       Impact factor: 2.998

2.  Ultrasound characterization of acoustic properties of acute intracardiac thrombi: studies in a new experimental model.

Authors:  D D McPherson; B M Knosp; R A Kieso; J A Bean; R E Kerber; D J Skorton; S M Collins
Journal:  J Am Soc Echocardiogr       Date:  1988 Jul-Aug       Impact factor: 5.251

3.  Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.

Authors:  Susan D Tiukinhoy-Laing; Shaoling Huang; Melvin Klegerman; Christy K Holland; David D McPherson
Journal:  Thromb Res       Date:  2006-08-02       Impact factor: 3.944

4.  Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents.

Authors:  S L Huang; A J Hamilton; A Nagaraj; S D Tiukinhoy; M E Klegerman; D D McPherson; R C Macdonald
Journal:  J Pharm Sci       Date:  2001-12       Impact factor: 3.534

5.  Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator.

Authors:  Melvin E Klegerman; Yuejiao Zou; David D McPherson
Journal:  J Liposome Res       Date:  2008       Impact factor: 3.648

6.  Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study.

Authors:  Jürgen Eggers; Inke R König; Björn Koch; Götz Händler; Günter Seidel
Journal:  Stroke       Date:  2008-03-13       Impact factor: 7.914

7.  Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience.

Authors:  Sanjiv Parikh; Amir Motarjeme; Thomas McNamara; Rodney Raabe; Klaus Hagspiel; James F Benenati; Keith Sterling; Anthony Comerota
Journal:  J Vasc Interv Radiol       Date:  2008-04       Impact factor: 3.464

8.  Treatment of critical limb ischemia using ultrasound-enhanced thrombolysis (PARES Trial): final results.

Authors:  Christian Wissgott; André Richter; Peter Kamusella; Hermann J Steinkamp
Journal:  J Endovasc Ther       Date:  2007-08       Impact factor: 3.487

9.  Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.

Authors:  Andrei V Alexandrov; Carlos A Molina; James C Grotta; Zsolt Garami; Shiela R Ford; Jose Alvarez-Sabin; Joan Montaner; Maher Saqqur; Andrew M Demchuk; Lemuel A Moyé; Michael D Hill; Anne W Wojner
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

  9 in total
  18 in total

Review 1.  Liposomes in diagnosis and treatment of cardiovascular disorders.

Authors:  Tatyana S Levchenko; William C Hartner; Vladimir P Torchilin
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

Review 2.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

3.  Relationship between cavitation and loss of echogenicity from ultrasound contrast agents.

Authors:  Kirthi Radhakrishnan; Kenneth B Bader; Kevin J Haworth; Jonathan A Kopechek; Jason L Raymond; Shao-Ling Huang; David D McPherson; Christy K Holland
Journal:  Phys Med Biol       Date:  2013-09-04       Impact factor: 3.609

4.  Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model.

Authors:  Susan T Laing; Melanie R Moody; Hyunggun Kim; Beverly Smulevitz; Shao-Ling Huang; Christy K Holland; David D McPherson; Melvin E Klegerman
Journal:  Thromb Res       Date:  2011-11-30       Impact factor: 3.944

5.  In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model.

Authors:  Xing Hua; Lina Zhou; Ping Liu; Yun He; Kaibin Tan; Qinghai Chen; Yuejuan Gao; Yunhua Gao
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

6.  Design of nanovectors for therapy and imaging of cardiovascular diseases.

Authors:  Omolola Eniola-Adefeso; Michael J Heslinga; Tyrone M Porter
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

7.  Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression.

Authors:  Melvin E Klegerman; Ali K Naji; Kevin J Haworth; Yuejiao Zou; Eva Golunski; Tao Peng; George L Britton; Shao-Ling Huang; Christy K Holland; David D McPherson
Journal:  J Liposome Res       Date:  2015-04-13       Impact factor: 3.648

8.  Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery.

Authors:  Shirshendu Paul; Rahul Nahire; Sanku Mallik; Kausik Sarkar
Journal:  Comput Mech       Date:  2014-03       Impact factor: 4.014

9.  Polymer-coated echogenic lipid nanoparticles with dual release triggers.

Authors:  Rahul Nahire; Manas K Haldar; Shirshendu Paul; Anaas Mergoum; Avinash H Ambre; Kalpana S Katti; Kara N Gange; D K Srivastava; Kausik Sarkar; Sanku Mallik
Journal:  Biomacromolecules       Date:  2013-02-20       Impact factor: 6.988

10.  Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.

Authors:  Hyunggun Kim; Patrick H Kee; Yonghoon Rim; Melanie R Moody; Melvin E Klegerman; Deborah Vela; Shao-Ling Huang; David D McPherson; Susan T Laing
Journal:  Atherosclerosis       Date:  2013-10-05       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.